Bilaketaren emaitzak - Sanchez Gonzalez, Yuri

Clinical and Economic Burden of Patients with Chronic Hepatitis C with Versus Without Antiviral Treatment in Japan: An Observational Cohort Study Using Hospital Claims Data nork Yamazaki, Kiyotaka, Macaulay, Dendy, Song, Yan, Sanchez Gonzalez, Yuri

Testu osoa Testu osoa Testu osoa

The Economic Value of Improved Productivity from Treatment of Chronic Hepatitis C Virus Infection: A Retrospective Analysis of Earnings, Work Loss, and Health Insurance Data nork Sulkowski, Mark, Ionescu-Ittu, Raluca, Macaulay, Dendy, Sanchez-Gonzalez, Yuri

Testu osoa Testu osoa Testu osoa

Value of Treating All Stages of Chronic Hepatitis C: A Comprehensive Review of Clinical and Economic Evidence nork Nuño Solinís, Roberto, Arratibel Ugarte, Patricia, Rojo, Ander, Sanchez Gonzalez, Yuri

Testu osoa Testu osoa Testu osoa

Clinical and Economic Burden of Hepatic and Extrahepatic Complications from Chronic Hepatitis C: A Retrospective Analysis of German Sickness Fund Data nork Kraus, Michael R., Kleine, Henning, Thönnes, Stefanie, Pignot, Marc, Sanchez Gonzalez, Yuri

Testu osoa Testu osoa Testu osoa

Improvement of Hepatic and Extrahepatic Complications from Chronic Hepatitis C After Antiviral Treatment: A Retrospective Analysis of German Sickness Fund Data nork Kraus, Michael R., Kleine, Henning, Thönnes, Stefanie, Pignot, Marc, Sanchez Gonzalez, Yuri

Testu osoa Testu osoa Testu osoa

Pan-Genotypic Hepatitis C Treatment with Glecaprevir and Pibrentasvir for 8 Weeks Resulted in Improved Cardiovascular and Metabolic Outcomes and Stable Renal Function: A Post-Hoc A... nork Tran, Tram T., Mehta, Darshan, Mensa, Federico, Park, Caroline, Bao, Yanjun, Sanchez Gonzalez, Yuri

Testu osoa Testu osoa Testu osoa

Estimating the Year Each State in the United States Will Achieve the World Health Organization’s Elimination Targets for Hepatitis C nork Sulkowski, Mark, Cheng, Wei-Han, Marx, Steven, Sanchez Gonzalez, Yuri, Strezewski, John, Reau, Nancy

Testu osoa Testu osoa Testu osoa

Effect of Hepatitis C Treatment with Ombitasvir/Paritaprevir/R + Dasabuvir on Renal, Cardiovascular and Metabolic Extrahepatic Manifestations: A Post-Hoc Analysis of Phase 3 Clinic... nork Mehta, Darshan A., Cohen, Eric, Charafeddine, Mariem, Cohen, Daniel E., Bao, Yanjun, Sanchez Gonzalez, Yuri, Tran, Tram T.

Testu osoa Testu osoa Testu osoa

Hepatitis C in Lebanon: the burden of the disease and the value of comprehensive screening and treatment nork Abou Rached, Antoine, Abou Kheir, Selim, Saba, Jowana, Assaf, Salwa, Kassis, Georges, Sanchez Gonzalez, Yuri, Ethgen, Olivier

Testu osoa Testu osoa Testu osoa

Quality of Life and Work Productivity Improvements with Upadacitinib: Phase 2b Evidence from Patients with Moderate to Severe Crohn’s Disease nork Peyrin-Biroulet, Laurent, Louis, Edouard, Loftus, Edward V., Lacerda, Ana, Zhou, Qian, Sanchez Gonzalez, Yuri, Ghosh, Subrata

Testu osoa Testu osoa Testu osoa

Upadacitinib Treatment Improves Symptoms of Bowel Urgency and Abdominal Pain, and Correlates With Quality of Life Improvements in Patients With Moderate to Severe Ulcerative Coliti... nork Ghosh, Subrata, Sanchez Gonzalez, Yuri, Zhou, Wen, Clark, Ryan, Xie, Wangang, Louis, Edouard, Loftus, Edward V, Panes, Julian, Danese, Silvio

Testu osoa Testu osoa Testu osoa

Addressing HCV Elimination Barriers in Italy: Healthcare Resource Utilization and Cost Impact Using 8 Weeks’ Glecaprevir/Pibrentasvir Therapy nork Andreoni, Massimo, Di Perri, Giovanni, Persico, Marcello, Marcellusi, Andrea, Ethgen, Olivier, Sanchez Gonzalez, Yuri, Bondin, Mark, Zhang, Zhenzhen, De Michina, Antonella, Merolla, Rocco Cosimo Damiano, Craxì, Antonio

Testu osoa Testu osoa Testu osoa